Twist Bioscience Launches 96-Plex Library Prep Kit for Low Pass High Throughput Next-Generation Sequencing

-- Further enables customers to convert from SNP microarray to NGS-based approach -- SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of synthetic DNA using its silicon platform, today announced the launch of the Twist 96-Plex Library Prep Kit, a high-performance, cost-effective preparation kit [...]

Using AI to Support Laboratory Practice Reforms at Research Sites Shimadzu Releases Peakintelligence Ver. 2.1 AI Software for LC-MS/MS

Shimadzu Corporation has developed Peakintelligence Ver. 2.1 (hereinafter “Ver. 2.1”) software for triple quadrupole liquid chromatograph mass spectrometers (LC-MS/MS). This software is equipped with algorithms developed using artificial intelligence (AI). Sale is scheduled to start worldwide in late December 2021. This version is the successor to Peakintelligence Ver. 2 (hereinafter “Ver. 2”), released in July [...]

BC Platforms Delivers on Global Real-World Data and Platform Access

Company poised to transform personalized drug development and clinical healthcare in 2022, following series of key pharma partnerships leveraging its leading genomics platform and global real-world data access network Latest partnership, with the Colorado Center for Personalised Medicine, could prove pivotal for identifying gene-drugs conflicts in clinical practice BC Platforms (BCP), a global leader in [...]

EVIDENT powered by OLYMPUS

Earlier this year, Olympus announced its plans to reorganize the Scientific Solutions Division into a self-sustainable company. This reorganization will enable the Scientific Solutions business a greater level of autonomy and agility to respond more quickly and with more flexibility to our industrial and life science customers’ needs. Today, we are proud to inform you [...]

Utility of World’s first Robot-compatible Autonomous Laboratory System with LC and LC-MS Units Verified with Kobe University

Shimadzu Corporation and Kobe University have started verifying the utility of a prototype autonomous laboratory system based on using robotic, digital, AI, and other technologies. The intention is to develop an autonomous laboratory system that is actually used in society, such as for developing biotechnology, pharmaceuticals, or new materials. Shimadzu Corporation has been jointly researching [...]

Eppendorf Research plus is the first pipette to receive My Green Lab ACT label

The Eppendorf Research® plus single-channel pipette line-up with variable volume has been certified with an “ACT®” Environmental Impact Factor Label by the “My Green Lab®” non-profit organization. By emphasizing Accountability, Consistency, and Transparency (ACT) around manufacturing, energy and water use, packaging, and end-of-life, the ACT label makes it easier for labs to choose more sustainable [...]

Westlake Omics Authorized as the Exclusive Distributor and Service Provider of Pressure BioSciences, Inc. in China

HANGZHOU, China -- The Agreement signed by Westlake Omics (Hangzhou) Biotechnology Co., Ltd (hereinafter referred to as Westlake Omics) and Pressure BioSciences, Inc. (hereinafter referred to as PBI) on December 3, 2021 authorized Westlake Omics as the exclusive distributor and service provider for PBI's PCT Sample Preparation System Platform and related products in China, a move that enables Westlake [...]

Notice Concerning Reorganization of Scientific Solutions Business through Company Split (Simple Absorption-type Split)

Company: Olympus Corporation Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi (Code: 7733, First Section, Tokyo Stock Exchange) Contact: Takaaki Sakurai, Vice President, Investor Relations Olympus Corporation ("Olympus") hereby announces that our board of directors has resolved at a meeting held today to transfer our scientific solutions business through an absorption-type company split (the [...]

Notice Concerning Reorganization of Scientific Solutions Business through Company Split (Simple Absorption-type Split)

Company: Olympus Corporation Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi (Code: 7733, First Section, Tokyo Stock Exchange) Contact: Takaaki Sakurai, Vice President, Investor Relations Olympus Corporation ("Olympus") hereby announces that our board of directors has resolved at a meeting held today to transfer our scientific solutions business through an absorption-type company split (the [...]

Services to Accelerate Genome Editing Research

AMSBIO has expanded its range of custom gene editing services to complement its extensive portfolio of off-the-shelf CRISPR/Cas9 products. A powerful technology, widely used in genome science, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) / Cas9 is a simple and efficient editing tool which allows for specific genome disruption and replacement facilitating the manipulation of [...]

Access IBO on Knowledge Center